News

In this Q&A, Dr. Saag discusses the status of prednisone to treat rheumatoid arthritis, new treatments for osteoporosis and more.

The Rheumatology Journal Club will explore the connection between polymyalgia rheumatic, giant cell arteritis (GCA) and the varicella-zoster virus during its Feb. 25 Twitter chat.

For rheumatology patients, opioids have more immediate risks than addiction, says the University of Michigan's Daniel Clauw, M.D., in an interview with Rheumatology Network.

By advocating, providing education and keeping an eye out for red flags, excellent nurses can play a critical role in keeping patients safe and healthy. Here are some ways that nurses help doctors to do their jobs better.

When more and more women with fibromyalgia began seeking care for pelvic pain syndromes, researchers from Oregon Health & Science University set out to examine the connection in a larger group of patients.

The Health Insurance Portability and Accountability Act (HIPAA) started out as a good idea. But, many medical professionals have started to read too far into HIPAA, making doctors’ jobs more difficult and, in some cases, affecting current and future patient care.

Research points to evidence showing that microorganisms inside our bodies could play a role in the development of arthritis, but it could also be a new therapeutic pathway.

To be young and African-American with a connective tissue disease, such as rheumatoid arthritis, means possibly facing a greater risk of developing some types of heart disease.

The lack of patient-doctor communication about osteoarthritis symptoms leaves patients in quandary about their condition, a study shows.

Blood analysis in patients with inflammatory rheumatic diseases such as psoriatic arthritis indicates that biologic medications do not reduce the efficacy of anti-pneumococcal polysaccharide vaccine, and that patients with such conditions may not need to be vaccinated more frequently than others.

Foot orthoses and rocker soles can reduce pressure under the first metatarsophalangeal joint associated with osteoarthritis.

Anemia could increase the prevalence of restless legs syndrome in patients with lupus.

In early rheumatoid arthritis, disease activity and pain do not necessarily occur in parallel.

A recent study showed that a large number of surgeons in the United States are reaching retirement age with no plans to put down their scalpel. What this can mean to the patients they treat has yet to be determined.

Biologic drug secukinumab (Cosentyx/Novartis), already FDA approved in January 2015 to treat chronic plaque psoriasis, has now been approved for two new indications: the treatment of active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).

A new patient registry analysis assessed whether there were any significant differences in outcome between combination therapy and monotherapy in patients with psoriatic arthritis.

Author of the recent vitamin D study in JAMA Internal Medicine discusses whether less is really more when it comes to vitamin D intake.

Graded drug challenges are considered the gold standard for evaluating patients with a low-risk history of a prior adverse drug reactions – like a mild rash or unknown reaction to penicillin as a child.

You’ve heard it thousands of times over the years: smoking is bad for your health. But a recent study found that cigarettes have an interesting impact when it comes to the risk of gout.

Sometimes health stories can be just downright strange, and even the most experienced physicians may scratch their heads from time to time. Whether it was strange ingredients to treat pain or foods that harmfully impact the body, there have been a fair share of wild occurrences in the past 12 months.

Part of an ongoing series that takes a high-level look at the positions of the leading nominees for President when it comes to political issues potentially impacting physicians, this installment focuses on Ben Carson.

The latest US Food and Drug Administration (FDA) approval goes to a Zurampic (lesinurad), a drug to help treat gout, a type of arthritis classified by severely painful joints.

Research points to the promise of rituximab as a second-line option for patients who do not respond to anti-TNF agents.

A head-to-head test of seven biologic agents finds that all are similarly effective in treating rheumatoid arthritis.

A Phase II trial of a new monoclonal antibody drug shows promise for a potential new treatment for lupus.

Physicians don't have enough time to properly research each medication on their own. The pharmaceutical industry needs to better teach physicians about their medications instead of driving patients to demand them.

A new study suggests that bone material strength index (BMSi) is weakly associated with spine and hip areal bone mineral density (aBMD) but not with prevalent fracture in women.

Hormone-related metabolic pathways in early rheumatoid arthritis may be at play, study shows.

With the amount of information we are hit with day in and day out, our minds need a way of quickly triaging it. This is what stereotyping does. But let's not confuse stereotyping with prejudice. The latter is negative and the former doesn't have to be.

Behcet's syndrome continues to puzzle rheumatologists.Several studies in 2014 and 2015 examined various aspects of this rare disorder.